A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer

Published:2017-04-21 Issue:5 Volume:17 Page:2913-2920
ISSN:1530-6984
Container-title:Nano Letters
language:en
Short-container-title:Nano Lett.

Author:

Shen Jianliang¹^ORCID,Kim Han-Cheon¹,Wolfram Joy¹²,Mu Chaofeng¹^ORCID,Zhang Wei³,Liu Haoran¹,Xie Yan¹⁴^ORCID,Mai Junhua¹,Zhang Hang³,Li Zhi¹,Guevara Maria¹,Mao Zong-Wan³^ORCID,Shen Haifa¹⁵

Affiliation:

1. Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas 77030, United States

2. Department of Transplantation, Mayo Clinic, Jacksonville, Florida 32224, United States

3. MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry and Chemical Engineering, Sun Yat-sen University, Guangzhou, 510275, China

4. Research Center for Health and Nutrition, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China

5. Department of Cell and Developmental Biology, Weill Cornell Medicine, New York, New York 10065, United States

Funder

U.S. Department of Health and Human Services

Ministry of Education of the People's Republic of China

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Mechanical Engineering,Condensed Matter Physics,General Materials Science,General Chemistry,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.nanolett.7b00132

Reference52 articles.

1. New trends for metal complexes with anticancer activity

2. Metallomics insights into the programmed cell death induced by metal-based anticancer compounds

3. Mechanistic insight into the cellular uptake and processing of cisplatin 30 years after its approval by FDA

4. Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects

5. Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: A systematic review of randomized controlled trials

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing anticancer treatment: Ruthenium-based nanoplatforms pave new paths;Coordination Chemistry Reviews;2024-11

2. The use of nanomaterials as drug delivery systems and anticancer agents in the treatment of triple-negative breast cancer: an updated review (year 2005 to date);Discover Nano;2024-09-03

3. Enhancing RNA detection and breast cancer subtyping with a universal 3D-hybridization chain reaction system;Talanta;2024-09

4. Liposomal Formulations of Metallodrugs for Cancer Therapy;International Journal of Molecular Sciences;2024-08-28

5. Shining New Light on Biological Systems: Luminescent Transition Metal Complexes for Bioimaging and Biosensing Applications;Chemical Reviews;2024-07-25